Tatva
TATVA.NSTatva Chintan Pharma Chem Limited Price (TATVA.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
22,889,189
(3.267)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,337,000,000 | 2,024,490,000 | 2,576,850,000 | 2,968,570,000 | 4,312,930,000 | 4,236,120,000 | 3,904,950,000 |
| Net Income | 122,890,000 | 205,430,000 | 377,890,000 | 522,620,000 | 958,740,000 | 454,870,000 | 303,540,000 |
| FCF USD | -200,490,000 | -24,300,000 | -228,600,000 | 33,490,000 | -687,790,000 | -1,753,270,000 | -304,710,000 |
| OCF USD | 104,120,000 | 73,560,000 | 253,120,000 | 243,190,000 | 203,780,000 | 277,830,000 | 980,440,000 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 1.15 | 0.81 | 0.44 | 0.13 | 0.09 | 0.02 |
| D/E | 0.95 | 0.97 | 0.77 | 0.54 | 0.25 | 0.33 | 0.02 |
| CA/CL | 1.22 | 1.57 | 1.51 | 1.56 | 2.54 | 1.33 | 3.74 |
| TA/TL | 1.69 | 1.74 | 1.90 | 2.12 | 3.55 | 3.13 | 10.03 |
| Total Debt | 561,460,000 | 771,480,000 | 906,890,000 | 902,480,000 | 1,199,380,000 | 1,702,570,000 | 142,710,000 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| ROIC | 10.41% | 14.81% | 19.84% | 20.01% | 15.64% | 8.71% | 3.91% |
| ROE | 20.79% | 25.78% | 32.11% | 31.49% | 20.27% | 8.84% | 4.12% |
| ROA | 0.00% | 14.61% | 19.12% | 19.28% | 15.82% | 5.92% | 3.71% |
| NM % | 9.19% | 10.15% | 14.66% | 17.61% | 22.23% | 10.74% | 7.77% |
| FCF / R% | 0.00% | -1.20% | -8.87% | 1.13% | -15.95% | -41.39% | -7.80% |
| FCF / NI% | -163.15% | -8.87% | -48.03% | 5.52% | -66.06% | -391.54% | -100.39% |
| Operating Margin (OM) | 0.00 | 0.35 | 0.42 | 0.49 | 0.56 | 0.67 | 0.79 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| EPS | 6.12 | 10.23 | 18.81 | 26.02 | 44.59 | 20.52 | 13.26 |
| SPS | 66.56 | 100.78 | 128.28 | 147.78 | 200.61 | 191.12 | 170.59 |
| OCPS | 5.18 | 3.66 | 12.60 | 12.11 | 9.48 | 12.53 | 42.83 |
| FCPS | -9.98 | -1.21 | -11.38 | 1.67 | -31.99 | -79.10 | -13.31 |
| BVPS | 29.45 | 39.68 | 58.59 | 82.62 | 220.05 | 232.25 | 321.99 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| CAGR-EPS | 6.12 | 10.23 | 18.81 | 26.02 | 44.59 | 20.52 | 13.26 |
| CAGR-SPS | 66.56 | 100.78 | 128.28 | 147.78 | 200.61 | 191.12 | 170.59 |
| CAGR-OCPS | 5.18 | 3.66 | 12.60 | 12.11 | 9.48 | 12.53 | 42.83 |
| CAGR-FCPS | -9.98 | -1.21 | -11.38 | 1.67 | -31.99 | -79.10 | -13.31 |
| CAGR-BVPS | 29.45 | 39.68 | 58.59 | 82.62 | 220.05 | 232.25 | 321.99 |